Resistance to thyroid hormone due to defective thyroid receptor alpha
Open Access
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 29 (4) , 647-657
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (095564/Z/11/Z)
- National Institute for Health Research Cambridge Biomedical Research Centre (RG64245)
- British Thyroid Foundation (RG80460)
This publication has 37 references indexed in Scilit:
- Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor αProceedings of the National Academy of Sciences, 2013
- Clinical Phenotype and Mutant TRα1New England Journal of Medicine, 2012
- Thyroid Hormone Receptor α and Regulation of Type 3 DeiodinaseMolecular Endocrinology, 2011
- Nuclear Receptor Rev-Erbα: A Heme Receptor that Coordinates Circadian Rhythm and MetabolismNuclear Receptor Signaling, 2010
- Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and ChallengesEndocrinology, 2009
- Erythroid defects in TRα−/− miceBlood, 2008
- Locomotor Deficiencies and Aberrant Development of Subtype-Specific GABAergic Interneurons Caused by an Unliganded Thyroid Hormone Receptor α1Journal of Neuroscience, 2008
- Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor α1 can be ameliorated by T3 treatmentGenes & Development, 2005
- A Thyroid Hormone Receptor α Gene Mutation (P398H) Is Associated with Visceral Adiposity and Impaired Catecholamine-stimulated Lipolysis in MiceJournal of Biological Chemistry, 2003
- Gene regulation by thyroid hormone receptorsCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996